Investigating Causal Relations between Genetic-Related Intermediate Endophenotype and Risk of Chronic Prostatitis: Mendelian Randomization Study
- PMID: 36071874
- PMCID: PMC9441385
- DOI: 10.1155/2022/4560609
Investigating Causal Relations between Genetic-Related Intermediate Endophenotype and Risk of Chronic Prostatitis: Mendelian Randomization Study
Abstract
Objective: Prostatitis is a common disease of the male genitourinary system, which seriously disturbs the physical and mental health of male patients. It is related to many factors such as living habits, age, and race, but the etiology has not been fully elucidated. This study investigated whether there is a causal relationship between clinical biochemical indicators (i.e., intermediate phenotype) and prostatitis through Mendelian randomization. The subjects of the study were prostatitis patients and related SNPs in the Guangxi Fangchenggang health examination cohort.
Methods: According to the requirements of Mendelian randomization (MR), the single nucleotide polymorphisms (SNPs) related to prostatitis patients and 29 common SNPs related to clinical biochemical indicators were analyzed by linkage disequilibrium, and the calculated SNPs were selected. Finally, the related SNPs were analyzed by Mendelian randomization method.
Results: 15 biochemical indicators such as complement C4, FOL, CRP, HCY, and estradiol have shared chronic prostatitis SNP sites, and five qualified SNPs were finally screened for complement C4. Finally, complement C4 was obtained by Mendelian randomization method (P = 0.039), which was statistically significant. The other 28 clinical endophenotypes were all negative.
Conclusion: The results show that there was a causal relationship between complement C4 and prostatitis, and the more consistent SNP is rs2075799.
Copyright © 2022 Shengfeng Zhang et al.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Assessing the causal relationship between immune cells and prostatitis: evidence from bidirectional mendelian randomization analysis.Mamm Genome. 2024 Sep;35(3):474-483. doi: 10.1007/s00335-024-10044-5. Epub 2024 May 30. Mamm Genome. 2024. PMID: 38816661
-
The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study.Acta Diabetol. 2021 Mar;58(3):301-307. doi: 10.1007/s00592-020-01608-3. Epub 2020 Oct 28. Acta Diabetol. 2021. PMID: 33113028 Free PMC article.
-
No causal association between plasma homocysteine levels and atrial fibrillation: A Mendelian randomization study.Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):587-591. doi: 10.1016/j.numecd.2020.10.012. Epub 2020 Oct 21. Nutr Metab Cardiovasc Dis. 2021. PMID: 33250370
-
Mendelian Randomization: Principles and its usage in Lp(a) research.Atherosclerosis. 2022 May;349:36-41. doi: 10.1016/j.atherosclerosis.2022.04.013. Atherosclerosis. 2022. PMID: 35606074 Review.
-
Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study.Pregnancy Hypertens. 2021 Dec;26:17-23. doi: 10.1016/j.preghy.2021.08.112. Epub 2021 Aug 19. Pregnancy Hypertens. 2021. PMID: 34428710 Review.
Cited by
-
Specific gut microbiota may increase the risk of erectile dysfunction: a two-sample Mendelian randomization study.Front Endocrinol (Lausanne). 2023 Dec 18;14:1216746. doi: 10.3389/fendo.2023.1216746. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38192423 Free PMC article.
-
The mediating role of primary sclerosing cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomization.Sci Rep. 2024 Dec 28;14(1):31433. doi: 10.1038/s41598-024-83085-0. Sci Rep. 2024. PMID: 39732896 Free PMC article.
-
Review of Mendelian randomization studies on common male-specific diseases.Front Endocrinol (Lausanne). 2025 May 16;16:1541744. doi: 10.3389/fendo.2025.1541744. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40453586 Free PMC article.
-
Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization.Clin Mol Hepatol. 2024 Apr;30(2):150-153. doi: 10.3350/cmh.2024.0116. Epub 2024 Feb 22. Clin Mol Hepatol. 2024. PMID: 38385196 Free PMC article. No abstract available.
References
-
- Rees J., Abrahams M., Doble A., Cooper A., the Prostatitis Expert Reference Group (PERG) Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU International . 2015;116(4):509–525. doi: 10.1111/bju.13101. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous